Potent Efficacy of BCL2 Inhibition with ABT-199 in High-Risk Aggressive B-Lymphoma Models When Combined with Knockdown of MCL1

Autor: Li, Lingxiao *, Pongtornpipat, Praechompoo *, Tiutan, Timothy *, Kendrick, Samantha L., Park, Soyoung *, Persky, Daniel O, Rimsza, Lisa M., Puvvada, Soham D., Schatz, Jonathan H.
Zdroj: In Blood 6 December 2014 124(21):506-506
Databáze: ScienceDirect